Reimagining Your Rapid Diagnostic Test

Our track record in reimagining point of care diagnostics and expertise in device development mean we can offer you best-in-class OEM solutions with excellent usability, convenience, and performance.

Our unique, proprietary technologies improve rapid diagnostic testing by elevating ease-of-use and performance. Atomo’s patent and platform device portfolios provide an efficient and low-risk pathway from product development to commercialisation of your test.

Unmatched Usability

User-centred design for professional use and self-test applications.

Proven Performance

Award-winning devices mitigate user errors to give accurate results.

Efficient Development

Validated processes support effective device development pathways.

1. Select your RDT Platform

2. Customise your device

3. Commercialisation

The AtomoRapid™ range includes patented RDT platforms with assorted features to meet requirements for professional use and self-test applications.

Platforms are customisable to suit your requirements and can be modified to match the specific of your test strip.

From manufacturing process validation to post-launch marketing, benefit from Atomo’s dedicated support at every stage.

Featured Case Study – OEM Partner

NG Biotech: Pioneers in blood-based rapid hCG pregnancy testing

An ambitious company intent on being a global leader in its field, NG Biotech identified a game-changing growth opportunity for its blood-based pregnancy RDT and partnered with Atomo to bring its new products to market:


“We value how Atomo is committed to designing products that work to eliminate user errors. We knew that this would be vital if this project was to attract professional users who need to improve patient outcomes, and to attract OTC home-test customers who currently have no choice but urine based pregnancy tests which have some limitations.” Milovan Stankov Pugès, CEO, NG Biotech

To find out more about our OEM service, please complete and submit the enquiry form:

Atomo News

An interview with Atomo MD, John Kelly on our FY20 results and strong uplift in revenues.   Watch the full interview >  ...